Discordance of EGFR mutation status between primary lung adenocarcinomas and corresponding metastatic tumors and the sensitivity to EGFR tyrosine kinase inhibitors
Han, H.S., Yang, J., Choi, M.K., Kwon, J., Lee, K.H., Lee, O-J.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw383.48
Date:
October, 2016
File:
PDF, 61 KB
2016